Family and friends of a young girl from Gravesend have got together to make a video, to raise money, so she can have specialist cancer treatment in America. Seven year old Stacey Mowle, has neuroblastoma, a rare form of the illness.
It's the latest in a series of fundraising attempts by the local community, who've rallied round to help. Events include a Bushtucker trial and a record breaking attempt at the UK's biggest Conga.
Hundreds of people have been fundraising today for a little girl with a rare form of cancer called Neuroblastoma. Stacey Mowle's parents want to send her to America for specialist treatment.
Today they tried to break the record for the UK's longest Conga hoping to raise the half a million pounds they need. It's the latest event in their campaign, which has also involved holding their own Bushtucker trial.
Andrea Thomas went along to see the attempt and find out more about the appeal. She spoke to Stacey and her Dad Warren.
A community's attempt to save the life of a 7-year-old girl who has the rare form of cancer, Neuroblastoma, takers another step forward today. Time is not on Stacey Mowle's side. She's being treated at the Royal Marsden, but needs to try pioneering treatment in America.
Today, campaigners will try to break the UK record for the biggest Conga, with up to 2000 people taking part. It's one of many madcap fundraising efforts, including a Bushtucker Trial, complete with sheep's brains and mealworms.
Cancer Research UK scientists from the University of Southampton say there is new hope in the fight against childhood cancer. They have said they are seeing positive results in a pre-clinical trial that could bring treatments for a particular form of childhood cancer closer to reality.
Their study published in 'Clinical Cancer Research' has found that two antibodies developed by the Hampshire team help to boost the immune system to fight neuroblastoma - a form of childhood cancer which grows from undeveloped tissue of the nervous system.
Dr Juliet Gray, Senior Lecturer in Paediatric Oncology said: "Although this work is still at a pre-clinical stage, we hope it has enabled us to identify a way that we can provide effective immunotherapy treatment against neuroblastoma.
"More research is needed to understand how these antibodies work and how they should be used to treat neuroblastoma.
"Six out of ten children with neuroblastoma can be successfully treated with conventional chemotherapy.
"But for those children who don't respond well to this treatment, immunotherapy could become a vital new treatment option.".